Diffusion tensor imaging in the early phase of schizophrenia: What have we learned?

Journal of Psychiatric Research

Volumn 44, Issue 15, 2010, Pages 993-1004

  Peters, Bart D ^a   Blaas, J ^b   de Haan, Lieuwe ^c  

^a Rivierduinen ^*  (Netherlands)

^b MATERIALS INNOVATION INSTITUTE M2I   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cannabis; Diffusion tensor imaging; High risk; Schizophrenia; White matter

Indexed keywords

CANNABIS; NEUROLEPTIC AGENT; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2;

ADOLESCENT; AGING; ANISOTROPY; ARCUATE NUCLEUS; AUDITORY HALLUCINATION; BRAIN SIZE; CAPSULA INTERNA; CINGULATE GYRUS; CORPUS CALLOSUM; DEMOGRAPHY; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE DURATION; FRONTAL LOBE; GENETIC PREDISPOSITION; HIGH RISK BEHAVIOR; HIPPOCAMPUS; HUMAN; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NEUROANATOMY; NEUROTOXICITY; OLIGODENDROGLIA; PARIETAL LOBE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TEMPORAL LOBE; THALAMUS; TREATMENT OUTCOME; WHITE MATTER;

BRAIN; BRAIN MAPPING; DATABASES, FACTUAL; DEMOGRAPHY; DIFFUSION TENSOR IMAGING; HUMANS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 77958152951     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.05.003     Document Type: Review

References (134)

1. Andreasen N.C. A unitary model of schizophrenia: Bleuler's " fragmented phrene" as schizencephaly. Archives of General Psychiatry 1999 Sep, 56(9):781-787. Review.
2. Arévalo-Martín A., García-Ovejero D., Rubio-Araiz A., Gómez O., Molina-Holgado F., Molina-Holgado E. Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2. European Journal of Neuroscience 2007 Sep, 26(6):1548-1559.
3. Arndt S., Tyrrell G., Flaum M., Andreasen N.C. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine 1992, 22:379-388.
4. Arnone D., Barrick T.R., Chengappa S., Mackay C.E., Clark C.A., Abou-Saleh M.T. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage 2008, 41(3):1067-1074.
5. Arnone D., McIntosh A.M., Tan G.M., Ebmeier K.P. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophrenia Research 2008, 101(1-3):124-132.
6. Ashtari M., Cervellione K., Cottone J., Ardekani B.A., Sevy S., Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. Journal of Psychiatric Research 2009 Jan, 43(3):189-204.
7. Auer D.P., Wilke M., Grabner A., Heidenreich J.O., Bronisch T., Wetter T.C. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation. Schizophrenia Research 2001 Oct 1, 52(1-2):87-99.
8. Bartzokis G., Beckson M., Lu P.H., Nuechterlein K.H., Edwards N., Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Archives of General Psychiatry 2001, 58(5):461-465.
9. Bartzokis G. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 2002, 27:672-683.
10. Bartzokis G., Nuechterlein K.H., Lu P.H., Gitlin M., Rogers S., Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biological Psychiatry 2003 Mar 1, 53(5):412-421.
11. Bartzokis G., Lu P.H., Stewart S.B., Oluwadara B., Lucas A.J., Pantages J., et al. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophrenia Research 2009 Sep, 113(2-3):322-331.
12. Bava S., Frank L.R., McQueeny T., Schweinsburg B.C., Schweinsburg A.D., Tapert S.F. Altered white matter microstructure in adolescent substance users. Psychiatry Research: Neuroimaging 2009, 173(3):228-237.
13. Bava S., Jacobus J., Mahmood O., Yang T.T., Tapert S.F. Neurocognitive correlates of white matter quality in adolescent substance users. Brain and Cognition 2009, [Epub ahead of print].
14. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR in Biomedicine 2002, 15:435-455.
15. Benes F.M., Turtle M., Khan Y., Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Archives of General Psychiatry 1994, 51:477-484.
16. Bersani G., Orlandi V., Gherardelli S., Pancheri P. Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. Psychopathology 2002, 35:289-295.
17. Bloemen O.J., de Koning M.B., Schmitz N., Nieman D.H., Becker H.E., de Haan L., et al. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychological Medicine 2009 Nov 9, 1-8. [Epub ahead of print].
18. Buchsbaum M.S., Tang C.Y., Peled S., Gudbjartsson H., Lu D., Hazlett E.A., et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998 Feb 16, 9(3):425-430.
19. Bullmore E.T., Frangou S., Murray R.M. The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophrenia Research 1997, 28:143-156.
20. Cahn W., Hulshoff Pol H.E., Caspers E., van Haren N.E., Schnack H.G., Kahn R.S. Cannabis and brain morphology in recent-onset schizophrenia. Schizophrenia Research 2004, 67:305-307.
21. Camchong J., Lim K.O., Sponheim S.R., Macdonald A.W. Frontal white matter integrity as an endophenotype for schizophrenia: diffusion tensor imaging in monozygotic twins and patients' nonpsychotic relatives. Frontiers in Human Neuroscience 2009, 3:35.
22. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008 Jan, 65(1):28-37.
23. Carpenter D.M., Tang C.Y., Friedman J.I., Hof P.R., Stewart D.G., Buchsbaum M.S., et al. Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia. Neuroreport 2008 Sep 17, 19(14):1369-1372.
24. Casanova M.F., Zito M., Bigelow L.B., Berthot B., Sanders R.D., Kleinman J.E. Axonal counts of the corpus callosum of schizophrenic patients. The Journal of Neuropsychiatry and Clinical Neurosciences 1989, 1(4):391-393.
25. Chan W.Y., Yang G.L., Chia M.Y., Lau I.Y., Sitoh Y.Y., Nowinski W.L., et al. White matter abnormalities in first-episode schizophrenia: a combined structural MRI and DTI study. Schizophrenia Research 2010 Jan 5, [Epub ahead of print].
26. Chance S.A., Highley J.R., Esiri M.M., Crow T.J. Fiber content of the fornix in schizophrenia: lack of evidence for a primary limbic encephalopathy. American Journal of Psychiatry 1999 Nov, 156(11):1720-1724.
27. Chang L., Friedman J., Ernst T., Zhong K., Tsopelas N.D., Davis K. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biological Psychiatry 2007, 62(12):1396-1404.
28. Cheung V., Cheung C., McAlonan G.M., Deng Y., Wong J.G., Yip L., et al. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychological Medicine 2008, 38(6):877-885.
29. Christensen J., Holcomb J., Garver D.L. State-related changes in cerebral white matter may underlie psychosis exacerbation. Psychiatry Research: Neuroimaging 2004 Jan 15, 130(1):71-78.
30. Compton M.T., Furman A.C., Kaslow N.J. Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample. Schizophrenia Research 2004, 71:61-64.
31. Crow T.J., Paez P., Chance S.A. Callosal misconnectivity and the sex difference in psychosis. International Review of Psychiatry 2007 Aug, 19(4):449-457.
32. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives General of Psychiatry 2003 May, 60(5):443-456. Review.
33. De Bellis M.D., Van Voorhees E., Hooper S.R., Gibler N., Nelson L., Hege S.G., et al. Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders. Alcoholism: Clinical and Experimental Research 2008 Mar, 32(3):395-404.
34. Dekker N., Schmitz N., Peters B.D., van Amelsvoort T.A., Linszen D.H., de Haan L. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Research: Neuroimaging 2010 Jan 30, 181(1):51-56.
35. Delisi L.E., Bertisch H.C., Szulc K.U., Majcher M., Brown K., Bappal A., et al. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct Journal 2006 May 9, 3:17.
36. Ehrenreich H., Rinn T., Kunert H.J., Moeller M.R., Poser W., Schilling L., et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl) 1999, 142:295-301.
37. Ellison-Wright I., Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophrenia Research 2009 Mar, 108(1-3):3-10.
38. Federspiel A., Begre S., Kiefer C., Schroth G., Strik W.K., Dierks T. Alterations of white matter connectivity in first episode schizophrenia. Neurobiology of Disease 2006, 22(3):702-709.
39. Filippi M., Rocca M.A. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 2007 Jul, 4(3):401-413.
40. Fornito A., Yung A.R., Wood S.J., Phillips L.J., Nelson B., Cotton S., et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biological Psychiatry 2008, 64(9):758-765.
41. Friedman J.I., Tang C., Carpenter D., Buchsbaum M., Schmeidler J., Flanagan L., et al. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. American Journal of Psychiatry 2008 Aug, 165(8):1024-1032.
42. Friston K.J., Frith C.D. Schizophrenia: a disconnection syndrome?. Clinical Neuroscience 1995, 3(2):89-97.
43. Gasparotti R., Valsecchi P., Carletti F., Galluzzo A., Liserre R., Cesana B., et al. Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. Schizophrenia Research 2009, 108(1-3):41-48.
44. Gulani V., Webb A.G., Duncan I.D., Lauterbur P.C. Apparent diffusion tensor measurements in myelin-deficient rat spinal cords. Magnetic Resonance in Medicine 2001, 45:191-195.
45. Hampson A.J., Grimaldi M., Axelrod J., Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. The Proceedings of the National Academy of Sciences of the USA 1998 Jul 7, 95(14):8268-8273.
46. Hao Y., Liu Z., Jiang T., Gong G., Liu H., Tan L., et al. White matter integrity of the whole brain is disrupted in first-episode schizophrenia. NeuroReport 2006, 17(1):23-26.
47. Highley J.R., Esiri M.M., McDonald B., Cortina-Borja M., Herron B.M., Crow T.J. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 1999, 122:99-110.
48. Highley J.R., Esiri M.M., McDonald B., Roberts H.C., Walker M.A., Crow T.J. The size and fiber composition of the anterior commissure with respect to gender and schizophrenia. Biological Psychiatry 1999, 45(9):1120-1127.
49. Hlawitschka M., Scheuermann G. HOT-lines: tracking lines in higher order tensor fields. Proceedings IEEE Visualization 2005, October:59-64.
50. Hoptman M.J., Nierenberg J., Bertisch H.C., Catalano D., Ardekani B.A., Branch C.A., et al. A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophrenia Research 2008, 106:115-124.
51. Horsfield M.A., Jones D.K. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases - a review. NMR in Biomedicine 2002, 15:570-577.
52. Hugenschmidt C.E., Peiffer A.M., Kraft R.A., Casanova R., Deibler A.R., Burdette J.H., et al. Relating imaging indices of white matter integrity and volume in healthy older adults. Cerebral Cortex 2008 Feb, 18(2):433-442.
53. Hubl D., Koenig T., Strik W., Federspiel A., Kreis R., Boesch C., et al. Pathways that make voices: white matter changes in auditory hallucinations. Archives of General Psychiatry 2004, 61:658-668.
54. Hyde T.M., Ziegler J.C., Weinberger D.R. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Archives of Neurology 1992, 49:401-406.
55. Innocenti G.M., Ansermet F., Parnas J. Schizophrenia, neurodevelopment and corpus callosum. Molecular Psychiatry 2003, 8:261-274.
56. Jacobus J., McQueeny T., Bava S., Schweinsburg B.C., Frank L.R., Yang T.T., et al. White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicology and Teratology 2009, 31(6):349-355.
57. Kanaan R., Barker G., Brammer M., Giampietro V., Shergill S., Woolley J., et al. White matter microstructure in schizophrenia: effects of disorder, duration and medication. British Journal of Psychiatry 2009, 194(3):236-242.
58. Kanaan R.A., Borgwardt S., McGuire P.K., Craig M.C., Murphy D.G., Picchioni M., et al. Microstructural organization of cerebellar tracts in schizophrenia. Biological Psychiatry 2009, 66(11):1067-1069.
59. Karlsgodt K.H., van Erp T.G., Poldrack R.A., Bearden C.E., Nuechterlein K.H., Cannon T.D. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biological Psychiatry 2008, 63(5):512-518.
60. Karlsgodt K.H., Niendam T.A., Bearden C.E., Cannon T.D. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biological Psychiatry 2009 Sep 15, 66(6):562-569.
61. Kanayama G., Rogowska J., Pope H.G., Gruber S.A., Yurgelun-Todd D.A. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 2004, 176:239-247.
62. Kawashima T., Nakamura M., Bouix S., Kubicki M., Salisbury D.F., Westin C.F., et al. Uncinate fasciculus abnormalities in recent onset schizophrenia and affective psychosis: a diffusion tensor imaging study. Schizophrenia Research 2009 May, 110(1-3):119-126.
63. Keshavan M.S. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. Journal of Psychiatric Research 1999, 33:513-521.
64. Kim M., Ronen I., Ugurbil K., Kim D.S. Spatial resolution dependence of DTI tractography in human occipito-callosal region. NeuroImage 2006, 32:1243-1249.
65. Konrad A., Winterer G. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?. Schizophrenia Bulletin 2008 Jan, 34(1):72-92. Review.
66. Kubicki M., Park H., Westin C.F., Nestor P.G., Mulkern R.V., Maier S.E., et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 2005 Jul 15, 26(4):1109-1118.
67. Kyriakopoulos M., Perez-Iglesias R., Woolley J.B., Kanaan R.A., Vyas N.S., Barker G.J., et al. Effect of age at onset of schizophrenia on white matter abnormalities. British Journal of Psychiatry 2009, 195(4):346-353.
68. LaMantia A.S., Rakic P. Axon overproduction and elimination in the anterior commissure of the developing rhesus monkey. Journal of Comparative Neurology 1994, 340:328-336.
69. Lenroot R.K., Giedd J.N. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neuroscience & Biobehavioral Reviews 2006, 30(6):718-729.
70. Linszen D., van Amelsvoort T. Cannabis and psychosis: an update on course and biological plausible mechanisms. Current Opinion in Psychiatry 2007, 20(2):116-120.
71. Mandl R.C., Schnack H.G., Luigjes J., van den Heuvel M.P., Cahn W., Kahn R.S., et al. Tract-based Analysis of Magnetization Transfer Ratio and Diffusion Tensor Imaging of the Frontal and Frontotemporal Connections in Schizophrenia. Schizophrenia Bulletin 2008 Nov 27, [Epub ahead of print].
72. Marner L., Pakkenberg B. Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics. Journal of Psychiatric Research 2003 Nov-Dec, 37(6):539-547.
73. Matute C., Domercq M., Fogarty D.J., Pascual de Zulueta M., Sánchez-Gómez M.V. On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS. Advances in Experimental Medicine and Biology 1999, 468:97-107.
74. McIntosh A.M., Moorhead T.W., Job D., Lymer G.K., Muñoz Maniega S., McKirdy J., et al. The effects of a neuregulin 1 variant on white matter density and integrity. Molecular Psychiatry 2008, 13(11):1054-1059.
75. Mendelsohn A., Strous R.D., Bleich M., Assaf Y., Hendler T. Regional axonal abnormalities in first episode schizophrenia: preliminary evidence based on high b-value diffusion-weighted imaging. Psychiatry Research: Neuroimaging 2006, 146(3):223-229.
76. Misgeld T. Death of an axon: studying axon loss in development and disease. Histochemistry and Cell Biology 2005, 124(3-4):189-196.
77. Mitelman S.A., Torosjan Y., Newmark R.E., Schneiderman J.S., Chu K.W., Brickman A.M., et al. Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophrenia Research 2007 May, 92(1-3):211-224.
78. Mitelman S.A., Canfield E.L., Newmark R.E., Brickman A.M., Torosjan Y., Chu K.W., et al. Longitudinal assessment of gray and white matter in chronic schizophrenia: a combined diffusion-tensor and structural magnetic resonance imaging study. Open Neuroimaging Journal 2009 May 20, 3:31-47.
79. Molina-Holgado E., Vela J.M., Arévalo-Martín A., Almazán G., Molina-Holgado F., Borrell J., et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. Journal of Neuroscience 2002 Nov 15, 22(22):9742-9753.
80. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007 Jul 28, 370(9584):319-328.
81. Mori T., Ohnishi T., Hashimoto R., Nemoto K., Moriguchi Y., Noguchi H., et al. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Research: Neuroimaging 2007 Feb 28, 154(2):133-145.
82. Morris H.M., Stopczynski R.E., Lewis D.A. NPY mRNA expression in the prefrontal cortex: Selective reduction in the superficial white matter of subjects with schizoaffective disorder. Schizophrenia Research 2009 Dec, 115(2-3):261-269.
83. Muñoz Maniega S., Lymer G.K., Bastin M.E., Marjoram D., Job D.E., Moorhead T.W., et al. A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophrenia Research 2008, 106:132-139.
84. Murray R.M., O'Callaghan E., Castle D.J., Lewis S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin 1992, 18:319-332.
85. Nasrallah H.A. Neuropathology of the corpus callosum in schizophrenia. British Journal of Psychiatry 1982 Jul, 141:99-100.
86. Nestor P.G., Kubicki M., Niznikiewicz M., Gurrera R.J., McCarley R.W., Shenton M.E. Neuropsychological disturbance in schizophrenia: a diffusion tensor imaging study. Neuropsychology 2008 Mar, 22(2):246-254.
87. Ono J., Harada K., Takahashi M., Maeda M., Ikenaka K., Sakurai K., et al. Differentiation between dysmyelination and demyelination using magnetic resonance diffusional anisotropy. Brain Research 1995, 671:141-148.
88. Olsen K.A., Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiatrica Scandinavica 2006 Apr, 113(4):273-282.
89. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361(9354):281-288.
90. Peralta V., Cuesta M.J. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatrica Scandinavica 1992, 85:127-130.
91. Pérez-Iglesias R., Tordesillas-Gutiérrez D., Barker G.J., McGuire P.K., Roiz-Santiañez R., Mata I., et al. White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage 2010 Jan 1, 49(1):199-204.
92. Perkins D.O., Gu H., Boteva K., et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry 2005, 162:1785-1804.
93. Peters B.D., de Haan L., Dekker N., Blaas J., Becker H.E., Dingemans P.M., et al. White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis. Neuropsychobiology 2008, 58(1):19-28.
94. Peters B.D., Schmitz N., Dingemans P.M., van Amelsvoort T.A., Linszen D.H., de Haan L., et al. Preliminary evidence for reduced frontal white matter integrity in subjects at ultra-high-risk for psychosis. Schizophrenia Research 2009, 111(1-3):192-193.
95. Peters B.D., de Haan L., Vlieger E.J., Majoie C.B., den Heeten G.J., Linszen D.H. Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?. Psychopharmacology Bulletin 2009, 42(2):75-88.
96. Peters B.D., Duran M., Vlieger E.J., Majoie C.B., den Heeten G.J., Linszen D.H., et al. Polyunsaturated fatty acids and brain white matter anisotropy in recent-onset schizophrenia: a preliminary study. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009, 81(1):61-63.
97. Peters B.D., Dingemans P.M., Dekker N., Blaas J., Akkerman E., van Amelsvoort T.A., et al. White matter connectivity and psychosis in ultra-high-risk subjects: a diffusion tensor fiber tracking study. Psychiatry Research: Neuroimaging 2010 Jan 30, 181(1):44-50.
98. Pfefferbaum A., Adalsteinsson E., Sullivan E.V. Supratentorial profile of white matter microstructural integrity in recovering alcoholic men and women. Biological Psychiatry 2006 Feb 15, 59(4):364-372.
99. Pope H.G., Gruber A.J., Hudson J.I., Cohane G., Huestis M.A., Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug and Alcohol Dependence 2003, 69:303-310.
100. Price G., Bagary M.S., Cercignani M., Altmann D.R., Ron M.A. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. Journal of Neurology, Neurosurgery & Psychiatry 2005, 76(4):585-587.
101. Price G., Cercignani M., Parker G.J., Altmann D.R., Barnes T.R., Barker G.J., et al. Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage 2007, 35(2):458-466.
102. Price G., Cercignani M., Parker G.J., Altmann D.R., Barnes T.R., Barker G.J., et al. White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage 2008, 39(3):949-955.
103. Qiu A., Zhong J., Graham S., Chia M.Y., Sim K. Combined analyses of thalamic volume, shape and white matter integrity in first-episode schizophrenia. Neuroimage 2009 Oct, 47(4):1163-1171.
104. Rosenberger G., Kubicki M., Nestor P.G., Connor E., Bushell G.B., Markant D., et al. Age-related deficits in fronto-temporal connections in schizophrenia: a diffusion tensor imaging study. Schizophrenia Research 2008 Jul, 102(1-3):181-188.
105. Rottanburg D., Robins A.H., Ben-Arie O., Teggin A., Elk R. Cannabis-associated psychosis with hypomanic features. Lancet 1982, 2:1364-1366.
106. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., Birchwood M., Patterson P., Juckel G., Heinz A., Morrison A., Lewis S., von Reventlow H.G., Klosterkötter J. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Archives of General Psychiatry 2010 Mar, 67(3):241-251.
107. Scheller-Gilkey G., Lewine R.R., Caudle J., Brown F.W. Schizophrenia, substance use, and brain morphology. Schizophrenia Research 1999, 35:113-120.
108. Schmithorst V.J., Yuan W. White matter development during adolescence as shown by diffusion MRI. Brain and Cognition 2009 Jul 21.
109. Schneiderman J.S., Buchsbaum M.S., Haznedar M.M., Hazlett E.A., Brickman A.M., Shihabuddin L., et al. Age and diffusion tensor anisotropy in adolescent and adult patients with schizophrenia. Neuroimage 2009, 45(3):662-671.
110. Segal D., Koschnick J.R., Slegers L.H., Hof P.R. Oligodendrocyte pathophysiology: a new view of schizophrenia. International Journal of Neuropsychopharmacology 2007 Aug, 10(4):503-511.
111. Seok J.H., Park H.J., Chun J.W., Lee S.K., Cho H.S., Kwon J.S., et al. White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Schizophrenia Research 2007, 156:93-104.
112. Shergill S.S., Kanaan R.A., Chitnis X.A., O'Daly O., Jones D.K., Frangou S., et al. A diffusion tensor imaging study of fasciculi in schizophrenia. American Journal of Psychiatry 2007, 164:467-473.
113. Sigmundsson T., Suckling J., Maier M., Williams S., Bullmore E., Greenwood K., et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. American Journal of Psychiatry 2001 Feb, 158(2):234-243.
114. Spalletta G., Tomaiuolo F., Marino V., Bonaviri G., Trequattrini A., Caltagirone C. Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study. Schizophrenia Research 2003, 64:15-23.
115. Stirling J., White C., Lewis S., Hopkins R., Tantam D., Huddy A., et al. Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophrenia Research 2003, 65(2-3):75-86.
116. Sullivan E.V., Pfefferbaum A. Diffusion tensor imaging and aging. Neuroscience & Biobehavioral Reviews 2006, 30(6):749-761.
117. Szeszko P.R., Robinson D.G., Sevy S., Kumra S., Rupp C.I., Betensky J.D., et al. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. British Journal of Psychiatry 2007 Mar, 190:230-236.
118. Szeszko P.R., Robinson D.G., Ashtari M., Vogel J., Betensky J., Sevy S., et al. Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 2008 Apr, 33(5):976-984.
119. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362(9386):798-805.
120. Tuch DS, Weisskoff RM, Belliveau JW, Wedeen VJ. High angular resolution diffusion imaging of the human brain. In: Proceedings of the 7th annual meeting of ISMRM; 1999. p. 321..
121. Tzilos G.K., Cintron C.B., Wood J.B., Simpson N.S., Young A.D., Pope H.G., et al. Lack of hippocampal volume change in long-term heavy cannabis users. American Journal of Addiction 2005, 14:64-72.
122. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Research Bulletin 2001 Jul 15, 55(5):597-610.
123. Van der Stelt M., Veldhuis W.B., Maccarrone M., Bär P.R., Nicolay K., Veldink G.A., et al. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Molecular Neurobiology 2002, 26(2-3):317-346.
124. Van Nimwegen L., de Haan L., van Beveren N., van den Brink W., Linszen D. Adolescence, schizophrenia and drug abuse: a window of vulnerability. Acta Psychiatrica Scandinavica Suppl 2005, 427:35-42.
125. Wang F., Jiang T., Sun Z., Teng S.L., Luo X., Zhu Z., et al. Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. Journal of Psychiatry & Neuroscience 2009 May, 34(3):181-186.
126. Whalley H.C., Gountouna V.E., Hall J., McIntosh A., Whyte M.C., Simonotto E., et al. Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia. BMC Psychiatry 2007 Oct 29, 7:61.
127. White T., Schmidt M., Karatekin C. White matter 'potholes' in early-onset schizophrenia: a new approach to evaluate white matter microstructure using diffusion tensor imaging. Psychiatry Research: Neuroimaging 2009, 174(2):110-115.
128. White T., Magnotta V.A., Bockholt H.J., Williams S., Wallace S., Ehrlich S., et al. Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophrenia Bulletin 2009, [Epub ahead of print].
129. Wilson W., Mathew R., Turkington T., Hawk T., Coleman R.E., Provenzale J. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. Journal of Addictive Diseases 2000, 19:1-22.
130. Wolkin A., Choi S.J., Szilagyi S., Sanfilipo M., Rotrosen J.P., Lim K.O. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. American Journal of Psychiatry 2003 Mar, 160(3):572-574.
131. Wood S.J., Pantelis C., Velakoulis D., Yücel M., Fornito A., McGorry P.D. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin 2008, 34(2):322-329.
132. Wyckoff N., Kumar A., Gupta R.C., Alger J., Hwang S., Thomas M.A. Magnetization transfer imaging and magnetic resonance spectroscopy of normal-appearing white matter in late-life major depression. Journal of Magnetic Resonance Imaging 2003 Nov, 18(5):537-543.
133. Yoon B., Shim Y.S., Lee K.S., Shon Y.M., Yang D.W. Region-specific changes of cerebral white matter during normal aging: a diffusion-tensor analysis. Archives of Gerontology and Geriatrics 2008 Jul-Aug, 47(1):129-138.
134. Zou L.Q., Xie J.X., Yuan H.S., Pei X.L., Dong W.T., Liu P.C. Diffusion tensor imaging study of the anterior limb of internal capsules in neuroleptic-naive schizophrenia. Academic Radiology 2008 Mar, 15(3):285-289.